ATON
ATON
NASDAQ · Biotechnology

Alphaton Capital Corp

$0.30
-0.03 (-10.36%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +3,987.2% upside
Low Target $6.99
Average Target $12.09
High Target $15.02
Current Price $0.30
Current
$0.30
Target
$12.09
$6.99 $12.09 avg $15.02
Scenario Analysis
Bear Case
$6.99
2,263.1%
Low target
Base Case
$12.09
+3,987.2%
Avg target
Bull Case
$15.02
+4,977.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$15.82
-98.1% from high
52-Week Low
$0.32
+-7.7% from low
Target vs 52W High
$12.09
-23.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%